The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.50
Bid: 92.00
Ask: 97.00
Change: -1.50 (-1.56%)
Spread: 5.00 (5.435%)
Open: 96.00
High: 96.50
Low: 94.50
Prev. Close: 96.00
MVI Live PriceLast checked at -
Marwyn Value Investors is an Investment Trust

To achieve long-term capital appreciation through its investment in the Master Fund primarily by focusing in mid cap businesses headquartered in the UK, Europe or North America.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Mark Hodges to MAC II

20 Jun 2022 09:00

RNS Number : 4517P
Marwyn Value Investors Limited
20 June 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

LEI: 213800L5751QTTVEA774

 

Marwyn Value Investors Limited ("MVIL" or the "Company")

Appointment of Mark Hodges to Marwyn Acquisition Company II Limited

 

The Company notes today's announcement by Marwyn Acquisition Company II Limited ("MAC II") regarding the appointment of Mark Hodges with effect from 19 June 2022. In connection with this appointment, the strategy of MAC II has been refined such that it will now focus on pursuing acquisition opportunities in the financial services, consumer and technology sectors.

James Corsellis, Managing Partner of Marwyn Investment Management LLP (the Manager of MVIL), commented: "An appointment of Mark's calibre as Chairman in MAC II is a fantastic outcome for MVI as well as the UK public markets. He has extensive experience across large financial services and consumer businesses, which we believe to be complementary. His appointment is another opportunity for MVI to partner with an industry-leading operator, to execute buy-and-build strategies using publicly listed acquisition vehicles."

Summary Biography of Mark Hodges, Chairman

Mark has over 30 years'' experience across the financial services and consumer sectors, including extensive FTSE 100 PLC board experience with Centrica plc and Aviva plc. As former CEO of ReAssure, Mark led the business through the £425m acquisition of Quilter's UK Heritage business and oversaw the sale of Reassure to Phoenix Group Holdings in 2020 for £3.25bn. At the time of the sale, ReAssure had approximately £80bn of assets under administration, 4 million customers and approximately 2,500 employees.

Revised sector focus

In line with Mark's appointment, MAC II's initial focus for investment has been refined to the financial services, consumer and technology sectors.

Summary of Market Backdrop

The MAC II directors believe that the current market backdrop has amongst a range of drivers, four notable interrelated themes which the MAC II directors believe are shaping a clear customer need that remains largely unmet.

Changing Population and demographics

Per latest estimates, there are currently 21 million people aged 55 and over in the UK (2020) and 99 million people aged 55 and over in the US (2021).  This global trend is likely to have a significant impact on economies, social care systems and household finances and the MAC II directors believe future financial solutions will need to reflect an increasing level of intergenerational financial and social dependencies with financial products, advice and life solutions needing to be tailored to meet a spectrum of complex multi-generational needs.

Wealth transfer and the role of families

Intergenerational wealth transfer is expected to exceed US$68 trillion, with £5.5 trillion of this in the UK, underpinning the increasing importance of the role played by families in providing future financial solutions.

· In the UK, one in every two first-time buyers aged under 35 is receiving financial support from their parents;

· 71 per cent. of these new homeowners say they would not have been likely to buy without financial support from family or friends;

· 75 per cent. of parents provide financial support to children who have left home;

· 43 per cent. of parents with children aged 30+ say they are helping them financially;

· In the US in 2018, families and friends supported one in every five existing home buyers with the purchase of 1.2 million homes, financing US$317 billion worth of homes; and

· US parents are spending US$500 billion on their adult children per annum.

Social and non-financial family support

· 5.4 million people in the UK provide unpaid care for a friend or family member with over 1.4 million people providing fifty or more hours of care per week. The peak age of carers in the UK is 55-64 with 29 per cent. of adults providing care and 22 per cent. of people aged over 65 providing unpaid care.

· In the US, where 53 million people are providing unpaid care to an adult with health or functional needs. 61 per cent. of these carers are fully employed and 45 per cent. say caregiving had at least one financial impact (e.g. stopped saving or took on more debt).

· 10 million caregivers (25 per cent. of US caregivers) fall into the millennial age range (22-37), of which, 73 per cent. are employed but also spend an average of 21 hours a week caring for loved ones.

Concentration of wealth

· In the UK, household wealth is principally concentrated in property (36 per cent.) and pension assets (42 per cent.);

· In the US, household wealth is similarly concentrated in pensions (20 per cent.), real estate (24 per cent.) and equities (27 per cent.).

Opportunities for a new approach to family-focussed financial solutions

With the combination of these social and macroeconomic conditions and trends, the MAC II directors believe all generations are facing increasingly challenging financial situations which are creating several problems to be solved.

The MAC II directors believe there is a well-defined need and opportunity, now more than ever, for clear and impartial support and solutions to be provided to, and shared amongst, friends, family and peers.

Strategy Execution

MAC II intends to execute its strategy through a combination of selective M&A of platform and bolt-on businesses, potential strategic partnerships with established financial services operators as well as ongoing operational improvements. Target company market segments, principally expected to be in the UK and US, may include, but are not limited to:

· FinTech digital platforms

· Digital content platforms

· Life and pensions

· Life-insurance assets

· Lifetime mortgages and equity release

· Wealth managers and advisers

· Brokerage and associated services

· Mortgage advisory

· Healthcare related services

· Estate planning and associated legal and tax services

· Later life planning and assisted care services

Company enquiries:

Company Secretary - Aztec Financial Services (Jersey) Limited

Chris Copperwaite / Magdala Mullegadoo

Telephone: 01534 833000

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

Corporate Broker - Liberum Capital Limited

Chris Clarke / Owen Matthews

Telephone: 0203 100 2200

 

Notes to editors:

Marwyn Value Investors Limited is a closed-ended investment company on the London Stock Exchange Specialist Fund Segment - a fully regulated market for professional, institutional and sophisticated investors. Marwyn's previous 11 comparable listed acquisition companies which have completed a platform acquisition have delivered in excess of £4.5 billion in equity profits and an aggregate return on capital to shareholders of 127 per cent (as at 31 May 2022).

 

For further information see www.marwynvalue.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGRGDLRUDDGDG
Date   Source Headline
2nd May 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd May 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd May 202410:00 amRNSNet Asset Value - Ordinary Shares
1st May 20247:00 amRNSInterim Dividend to Ordinary Shareholders
30th Apr 20242:56 pmRNSShare Dealings
30th Apr 20247:00 amRNSAnnual Financial Statements December 2023
22nd Apr 202411:00 amRNSNet Asset Values
15th Apr 202411:00 amRNSNet Asset Values
9th Apr 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
9th Apr 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
9th Apr 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Mar 20243:26 pmRNSShare Transfer
21st Mar 20243:53 pmRNSNotification of Major Interests in Shares
21st Mar 20243:51 pmRNSNotification of Major Interests in Shares
20th Mar 20241:42 pmRNSShare Transfer
18th Mar 202411:00 amRNSNet Asset Values
11th Mar 202411:00 amRNSNet Asset Values
7th Mar 20241:52 pmRNSNotification of Major Interests in Shares
4th Mar 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Mar 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Mar 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
28th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
28th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
23rd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
23rd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
23rd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
14th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
2nd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
26th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
26th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
26th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
25th Jan 20247:00 amRNSInterim Dividend to Ordinary Shareholders
15th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
29th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
29th Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
29th Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
22nd Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
22nd Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
22nd Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
18th Dec 20235:53 pmRNSShare Dealings
15th Dec 202311:42 amRNSNotification of Major Interests in Shares
14th Dec 20231:02 pmRNSResult of AGM
14th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.